Table 4.
Nyvad’s scores [12] at the baseline and after 1 month of treatment (final) for TiF4, NaF and placebo treatments.
| Measures | TiF4 | NaF | Placebo | |||||
| Baseline | Final | Baseline | Final | Baseline | Final | |||
| Nyvad index, mean±SD | 1.0±0.00 | 1.0±0.00 | 0.97±0.15 | 1.03±0.15a | 0.99±0.06 | 1.08±0.24b | ||
| Dfc, median (min-max) | 0.0 (0.0 to 0.0) | 0.0 (–0.7 to 0.0) | 0.0 (–1.0 to 0.0) | |||||
aOne patient presented two teeth that progressed from score 0 to 1 and 1 patient had one lesion that progressed from score 1 to 3.
bOne patient presented one tooth that progressed from score 0 to 3 and one patient had one lesion that progressed from score 1 to 3.
cDf: degrees of freedom. Df = baseline – final value, where positive values indicate regression and negative values indicate lesions progression. Kruskal-Wallis Test (p=.39).